Monoclonal antibody targeting of anti-cancer agents.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D000954:Antigens, Surface / Q000276:immunology; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D016026:Bone Marrow Transplantation; D002352:Carrier Proteins / Q000627:therapeutic use; D003602:Cytotoxicity, Immunologic; D003911:Dextrans / Q000494:pharmacology; D004341:Drug Evaluation; D006801:Humans; D051379:Mice; D009374:Neoplasms, Experimental / Q000628:therapy; D012276:Ricin / Q000276:immunology / Q000302:isolation & purification / Q000494:pharmacology / Q000627:therapeutic use; D012709:Serum Albumin / Q000494:pharmacology; D014018:Tissue Distribution; D014118:Toxins, Biological / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D000954:Antigens, Surface; D000970:Antineoplastic Agents; D002352:Carrier Proteins; D003911:Dextrans; D012709:Serum Albumin; D014118:Toxins, Biological; D012276:Ricin